Natera, Inc.
Nasdaq NTRA · Austin, TX
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Natera, Inc. is a clinical trial sponsor based in Austin, TX, listed as Nasdaq NTRA. It has 15 active clinical trials with 54,420 planned participants, across 13 therapeutic areas. Since 2021 it has completed 6 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq NTRA
Pipeline · 15 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Natera, Inc
Natera, Inc is lead sponsor of 15 active clinical trials on ClinicalTrials.gov, with 54,420 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 6 trials and stopped 2 early.
Natera, Inc is based in Austin, TX and is listed as Nasdaq NTRA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Natera, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-23.
Approve Suite is not affiliated with Natera, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.